AMR Dialogues | Connecting the dots: Substandard and falsified medical products & Antimicrobial Resistance



According to the World Health Organization (WHO), substandard and falsified medical products affect people all around the world. At least 1 in 10 medicines in low- and middle-income countries are substandard or falsified.

Substandard products are those that do not meet quality standards and specifications, often due to poor manufacturing practices or inadequate quality control.

Substandard and falsified medical products pose significant threats to public health globally. They can be ineffective at treating the illness, as they may contain incorrect ingredients or incorrect dosages. They can even be directly harmful to patients if they contain contaminants or toxic substances. They may be indirectly harmful through increased risk of antimicrobial resistance (AMR).

Join us on 11th March, Tuesday, to learn more about this issue and its link to AMR. Also, learn more about The Trinity Challenge of GBP 1 Million competition to improve community access to effective antibiotics.

Tuesday, 11th March

4pm IST (90 minutes)
(1:30pm Kenya/ Ethiopia/ Uganda, 12:30pm South Africa/ Zimbabwe/ Zambia, 11:30am Geneva, 4:15pm Nepal, 4:30pm Bangladesh, 5pm Myanmar, 5:30pm Thailand, 6:30pm KL/ Manila)

Panel of experts
  • Dr Kamini Walia, Senior Scientist, who leads AMR initiatives at Indian Council of Medical Research (ICMR) and GAMA Scientific Chairperson
  • Dr Philip Mathew, Technical Officer, AMR Awareness, Campaigns and Advocacy Team, World Health Organization (WHO) HQ
  • Leena Menghaney, lawyer: public health, pharmaceuticals and access
  • Hamish Morrow, Project Manager, The Trinity Challenge (TTC)
  • Sriram Natarajan, Co-Founder, CEO and Director, Molbio Diagnostics
  • Ronika Susan George, Global Health Partnerships, Qure.AI
  • Shobha Shukla, Chairperson, Global AMR Media Alliance (GAMA) & CNS Founder Executive Director (Host)
click here or go to this link:
https://us06web.zoom.us/meeting/register/XqzdaacsSjugyPl_ft9VTA

Thanks

GAMA and CNS team